Home LiteratureArticle Details
PMID: 946099 Published · ppublish English Case Reports Journal Article

Hematin treatment of acute porphyria. Early remission of an almost fatal relapse.

JAMA ·Vol. 235 ·No. 5 ·1976-02-02 ·Pages 520-2

Peterson A, Bossenmaier I, Cardinal R, Watson CJ

Abstract

Intravenous infusions of hematin in a young woman with acute porphyria in profound relapse was followed within 48 hours by remission of symptoms and rapid recovery. From a state of severe central and peripheral nervous-system involvement, the patient recovered so completely that she was able to leave the hospital in less than a month, with only a residual weakness of her arms. Serial studies of serum and urinary levles of porphyrin precursors and serum level of hematin provided highly important information about the effect of hematin on acute porphyria.

MeSH Terms
Acute Disease Adult Aminolevulinic Acid/blood,urine Female Follow-Up Studies Heme/analogs & derivatives Hemin/administration & dosage,therapeutic use Humans Infusions, Parenteral Porphobilinogen/blood,urine Porphyrias/drug therapy,genetics Remission, Spontaneous
Chemicals
Heme Hemin Porphobilinogen Aminolevulinic Acid
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Peterson A
Bossenmaier I
Cardinal R
Watson C J
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
0098-7484
Published
1976-02-02
Pages
520-2
Language
English
Region
United States
NLM ID
7501160
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]